Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Guidance

Subcategories:Clinical Criteria/GuidelinesEthicsLegal UpdatesLegislation & AdvocacyMeeting ReportsResearch Rheum

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

High-resolution computed tomography shows evidence of ILD.

The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

 

ACR Winter Rheumatology Symposium: Tips for ANCA Testing

Kimberly Retzlaff  |  May 1, 2013

How to select the correct testing method and interpret conflicting results from antineutrophil cytoplasmic antibody tests

ACR Winter Rheumatology Symposium: The Search for Answers in Sjögren’s Syndrome

Kimberly Retzlaff  |  May 1, 2013

Research has led to greater understanding of the disease, potential for better treatment options

ACR Winter Rheumatology Symposium: Answers to Your Tough Questions about Rheumatic Disease Therapy

Kimberly Retzlaff  |  May 1, 2013

Panelists discuss vaccination, biologics and infection, methotrexate, cardiovascular risk, and serial immunoglobulin testing and imaging

ACR Winter Rheumatology Symposium: New Kinase Inhibitors Show Promise

Staff  |  May 1, 2013

Toxicity and appropriate targeting are challenges for small molecule researchers

Legal Updates: What Rheumatologists Should Consider Before Signing with an ACO

Steven M. Harris, Esq.  |  May 1, 2013

Medicare’s ACO physician exclusivity provisions may preclude participation in more than one accountable care organization

Large Genome Study Identifies Genetic Risk Factors for Gout

Lara C. Pullen, PhD  |  April 26, 2013

Researchers have identified 28 genome-wide significant urate concentration–associated loci, underscoring the importance of metabolic control in urate production.

Sequester Affects Rheumatologists on Two Fronts—Medicare Reimbursement and Research Funding

Richard Quinn  |  April 18, 2013

Rheumatologists are already feeling two effects from Congress’ inability to solve sequestration: a 2% reduction in Medicare reimbursements and slashed funding for research financed by the National Institutes of Health.

DNA Methylation Modifies Genetic Risk for Rheumatoid Arthritis

Lara C. Pullen, PhD  |  April 12, 2013

A first-of-its-kind study has been published that integrates genotype and epigenotype data across the entire genome.

President’s Perspective: ACR Calls on Members to Advance Rheumatology

Audrey B. Uknis, MD  |  April 1, 2013

Members’ support and participation is needed to strengthen the ACR’s lobbying efforts with Congress

How Rheumatologists Can Win Support and Influence Congress

Staff  |  April 1, 2013

Ways to use the ACR’s advocacy toolkit to contact Congressional representatives and articulate your message to lawmakers

  • « Previous Page
  • 1
  • …
  • 242
  • 243
  • 244
  • 245
  • 246
  • …
  • 308
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences